Defining cellular population dynamics at single-cell resolution during prostate cancer progression.
Alexandre A GermanosSonali AroraYe ZhengErica T GoddardIlsa M ColemanAnson T KuScott WilkinsonHanbing SongNicholas J BradyRobert A AmezquitaMichael A ZagerAnnalysa LongYu Chi YangJason H BielasRaphael GottardoDavid S RickmanFranklin W HuangCyrus M GhajarPeter S NelsonAdam G SowalskyManu SettyAndrew C HsiehPublished in: eLife (2022)
Advanced prostate malignancies are a leading cause of cancer-related deaths in men, in large part due to our incomplete understanding of cellular drivers of disease progression. We investigate prostate cancer cell dynamics at single-cell resolution from disease onset to the development of androgen independence in an in vivo murine model. We observe an expansion of a castration-resistant intermediate luminal cell type that correlates with treatment resistance and poor prognosis in human patients. Moreover, transformed epithelial cells and associated fibroblasts create a microenvironment conducive to pro-tumorigenic immune infiltration, which is partially androgen responsive. Androgen-independent prostate cancer leads to significant diversification of intermediate luminal cell populations characterized by a range of androgen signaling activity, which is inversely correlated with proliferation and mRNA translation. Accordingly, distinct epithelial populations are exquisitely sensitive to translation inhibition, which leads to epithelial cell death, loss of pro-tumorigenic signaling, and decreased tumor heterogeneity. Our findings reveal a complex tumor environment largely dominated by castration-resistant luminal cells and immunosuppressive infiltrates.
Keyphrases
- single cell
- prostate cancer
- poor prognosis
- rna seq
- radical prostatectomy
- cell death
- high throughput
- long non coding rna
- end stage renal disease
- cell cycle arrest
- endothelial cells
- induced apoptosis
- newly diagnosed
- single molecule
- chronic kidney disease
- ejection fraction
- anti inflammatory
- stem cells
- signaling pathway
- cell therapy
- gene expression
- middle aged
- peritoneal dialysis
- binding protein
- drug delivery
- smoking cessation
- pluripotent stem cells
- replacement therapy